Epperly Melissa B,
Transaction: 06/18/2026
BUY
Change
+45,000
Price
$2.28
Filing
06/22/2026
Type
BUY
Nautilus Biotechnolgy, Inc.
NAUT • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$237.64M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.19Healthy liquidity · 13.33Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Apr 28, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$237.64M
52W Range0.62 - 4.31
Beta0.75
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.19
Current Ratio13.33
Quick Ratio13.33
Target$2.50
Price$0.00
Change0.00%
Market Cap$237.64M
52W Range0.62 - 4.31
Beta0.75
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.19
Current Ratio13.33
Quick Ratio13.33
Target$2.50
Target Median$2.50
Target Range2.50 - 2.50
Volume803.15K
Avg Volume492.63K
EPS Surprise0.03
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
90/100
Why this score▼
Manageable debt level · 0.19Healthy liquidity · 13.33Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-07-01
Low
$2.50
Mean
$2.50
Median
$2.50
High
$2.50
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
McIlwain Matthew S
Transaction: 06/18/2026
BUY
Change
+45,000
Price
$2.28
Filing
06/22/2026
Type
BUY
Akinsanya Karen
Transaction: 06/18/2026
BUY
Change
+45,000
Price
$2.28
Filing
06/22/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Epperly Melissa B, | BUY | +45,000 | $2.28 | 06/18/2026 | 06/22/2026 |
| McIlwain Matthew S | BUY | +45,000 | $2.28 | 06/18/2026 | 06/22/2026 |
| Akinsanya Karen | BUY | +45,000 | $2.28 | 06/18/2026 | 06/22/2026 |
| NAZEM FARZAD | BUY | +45,000 | $2.28 | 06/18/2026 | 06/22/2026 |
| Posard Matthew L. | BUY | +45,000 | $2.28 | 06/18/2026 | 06/22/2026 |
| AH Equity Partners Bio II, L.L.C. | SELL | -384,026 | $2.35 | 06/02/2026 | 06/04/2026 |
| Patel Sujal M | BUY | +25,000 | $2.61 | 03/04/2026 | 03/04/2026 |
| Suzuki Kentaro | BUY | +160,000 | $2.32 | 03/02/2026 | 03/04/2026 |
| Murphy Matthew B. | BUY | +160,000 | $2.32 | 03/02/2026 | 03/04/2026 |
| Weld Gwen E | BUY | +160,000 | $2.32 | 03/02/2026 | 03/04/2026 |
| Sankar Subramanian | BUY | +160,000 | $2.32 | 03/02/2026 | 03/04/2026 |
| Patel Sujal M | BUY | +650,000 | $2.32 | 03/02/2026 | 03/04/2026 |
| Mallick Parag | BUY | +280,000 | $2.32 | 03/02/2026 | 03/04/2026 |
| Mowry Anna | BUY | +160,000 | $2.32 | 03/02/2026 | 03/04/2026 |
| Suzuki Kentaro | BUY | +4,000 | $1.49 | 11/06/2025 | 11/10/2025 |
| Patel Sujal M | BUY | +83,500 | $0.68 | 09/08/2025 | 09/09/2025 |
| Patel Sujal M | BUY | +116,500 | $0.67 | 09/05/2025 | 09/09/2025 |
| Murphy Matthew B. | BUY | +20,000 | $0.64 | 09/04/2025 | 09/05/2025 |
| Akinsanya Karen | BUY | +45,000 | $0.70 | 06/23/2025 | 06/25/2025 |
| NAZEM FARZAD | BUY | +45,000 | $0.70 | 06/23/2025 | 06/25/2025 |